Qianwen Xi

No ORCID on file · 4 papers in corpus
other 2025
Reproductive health ·doi:10.1186/s12978-025-01977-4
rct 2022
Reproductive health ·doi:10.1186/s12978-022-01500-z

BACKGROUND: This study aimed to investigate the medroxyprogesterone acetate (MPA) + HMG protocol vs ultra-long gonadotrophin releasing hormone (GnRH) agonist protocol in patients with advanced ovarian endometriosis who received in vitro fer…

observational 2022
Frontiers in endocrinology ·doi:10.3389/fendo.2022.922605

BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most common reasons for infertility. The consensus of the treatment of infertile women with PCOS is ovulation induction (OI) for six to nine attempts before in vitro fertilization (…

case-report 2020
Clinical epidemiology ·doi:10.2147/clep.s226414

PURPOSE: To investigate whether progestin-primed ovarian stimulation (PPOS) can be an alternative as gonadotrophin-releasing hormone agonist (GnRHa) long protocol for infertile women with normal ovarian reserve during IVF/ICSI. METHODS: A …